LMSD: Lipid classification search results


LM_IDCommon NameSystematic NameSpecies ShorthandFormulaMass
LMFA02020001Jasmonic acid (W)(1R,2R)-3-oxo-2-(pent-2Z-enyl)-
cyclopentaneacetic acid
FA 12:3;OC12H18O3210.1256
LMFA02020003(3R,7S)-iso-jasmonic acid(1R,2S)-3-oxo-2-(2'Z-pentenyl)-
cyclopentaneacetic acid
FA 12:3;OC12H18O3210.1256
LMFA02020004(3S,7R)-iso-jasmonic acid(1S,2R)-3-oxo-2-(2'Z-pentenyl)-
cyclopentaneacetic acid
FA 12:3;OC12H18O3210.1256
LMFA02020005(+)-7-epi--9,10-dihydrojasmonic acid(1S,2R)-3-oxo-2-pentyl-
cyclopentaneacetic acid
FA 12:2;OC12H20O3212.1412
LMFA02020006(-)-7-epi--9,10-dihydrojasmonic acid(1R,2S)-3-oxo-2-pentyl-
cyclopentaneacetic acid
FA 12:2;OC12H20O3212.1412
LMFA02020007Tuberonic acid(1R,2S)-3-oxo-2-(5'-hydroxy-2'Z-
pentenyl)-cyclopentaneacetic acid
FA 12:3;O2C12H18O4226.1205
LMFA02020008epi-4'-hydroxyjasmonic acid(1S,2R)-3-oxo-2-(4'-hydroxy-2'Z-
pentenyl)-cyclopentaneacetic acid
FA 12:3;O2C12H18O4226.1205
LMFA02020009cis-Jasmone (W)3-methyl-2-(pent-2Z-enyl)cyclopent-2-
enone
FA 11:3;OC11H16O164.1201
LMFA02020010Methyl jasmonate (W)methyl 2-((1R,2R)-3-oxo-2-pent-2Z-enyl)
cyclopentyl)acetate
FA 13:3;OC13H20O3224.1412
LMFA0202001112-hydroxyjasmonic acid{(1R,2R)-2-[(2Z)-5-hydroxypent-2-en-1-
yl]-3-oxocyclopentyl}acetic acid
FA 12:3;O2C12H18O4226.1205
LMFA02020012(-)-11-hydroxy-9,10-dihydrojasmonic
acid
[(1R,2R)-2-(4-hydroxypentyl)-3-
oxocyclopentyl]acetic acid
FA 12:2;O2C12H20O4228.1362
LMFA02020013(+)-cucurbic acid{(1R,2S,3S)-3-hydroxy-2-[(2Z)-pent-2-
en-1-yl]cyclopentyl}acetic acid
FA 12:2;OC12H20O3212.1412
LMFA02020015(-)-12-hydroxy-9,10-dihydrojasmonic
acid
[(1R,2R)-2-(5-hydroxypentyl)-3-
oxocyclopentyl]acetic acid
FA 12:2;O2C12H20O4228.1362
LMFA02020016methyl (+)-7-isojasmonatemethyl {(1R,2S)-3-oxo-2-[(2Z)-pent-2-
en-1-yl]cyclopentyl}acetate
FA 13:3;OC13H20O3224.1412
LMFA02020017(3S,7S)-Jasmonic acid(1S,2S)-3-oxo-2-(pent-2Z-enyl)-
cyclopentaneacetic acid
FA 12:3;OC12H18O3210.1256
LMFA02020204(-)-9,10-dihydrojasmonic acid[(1R,2R)-3-oxo-2-
pentylcyclopentyl]acetic acid
FA 12:2;OC12H20O3212.1412
LMFA02020205(+)-9,10-dihydrojasmonic acid[(1S,2S)-3-oxo-2-
pentylcyclopentyl]acetic acid
FA 12:2;OC12H20O3212.1412
LMFA02020206(-)-11-hydroxy-9,10-dihydrojasmonic
acid 11-β-D-glucoside
{(1R,2R)-2-[4-(β-D-glucopyranosyloxy)
pentyl]-3-oxocyclopentyl}acetic acid
FA 18:3;O7C18H30O9390.1890
LMFA0202020712-hydroxyjasmonic acid 12-O-β-D-
glucoside
2-((1R,2R)-2-((Z)-5-hydroxypent-2-enyl)
-3-oxocyclopentyl)acetic acid 5-O-β-D-
glucoside
FA 19:4;O6C19H30O8386.1941
LMFA02020208N-[9,10-Dihydrojasmonoyl]isoleucine[(1R,2R)-3-oxo-2-
pentylcyclopentyl]ethanoyl leucine
-C18H31NO4325.2253
LMFA02020209N-jasmonoyl-isoleucineN-({(1R,2R)-3-Oxo-2-[(2Z)-Pent-2-En-1-
Yl]cyclopentyl}acetyl)-L-Isoleucine
-C18H29NO4323.2097
LMFA02020210N-jasmonoyl-L-tyrosineN-({(1R,2R)-3-Oxo-2-[(2Z)-Pent-2-En-1-
Yl]cyclopentyl}acetyl)-L-tyrosine
-C21H27NO5373.1889
LMFA02020211N-jasmonoyl-L-dopaN-({(1R,2R)-3-Oxo-2-[(2Z)-Pent-2-En-1-
Yl]cyclopentyl}acetyl)-L-
dihydroxyphenylalanine
-C21H27NO6389.1838
LMFA02020212N-jasmonoyl-dopamineN-({(1R,2R)-3-Oxo-2-[(2Z)-Pent-2-En-1-
Yl]cyclopentyl}acetyl)-dopamine
-C20H27NO4345.1940
LMFA02020213-(1R,2R,2'E)-2-(5'-ethoxy-5'-oxo-2-
penten-1-yl)-3-oxo-cyclopentane acetic
acid methyl ester
FA 15:4;O3C15H22O5282.1467
LMFA02020214-(1R,2R,2'E)-2-(5'-methoxy-5'-oxo-2-
penten-1-yl)-3-oxo-cyclopentane acetic
acid ethyl ester
FA 15:4;O3C15H22O5282.1467
LMFA02020215-(1R,2R,2'E)-2-[5'-(hydroxy)-2-penten-1-
yl]-3-oxocyclopentane acetic acid
methyl ester
FA 13:3;O2C13H20O4240.1362
LMFA02020216-methyl 2-((1R,2R)-2-((E)-5'-
phenylacetoxypent-2-en-1-yl)-3-
oxocyclopentyl) acetate
FA 21:8;O3C21H26O5358.1780
LMFA02020217-2-(2'-trans-pentenyl-5'-hydroxy)-3-
methyl-2-cyclopenten-1-one
FOH 11:4;OC11H16O2180.1150
LMFA02020218Methyl 12-hydroxyjasmonatemethyl (1R,2R,2'Z)-2-(5'- hydroxy-2'-
enyl)-3-oxo-cyclopentane-acetate
FA 13:3;O2C13H20O4240.1362
LMFA02020219-1R,2R,2'E)-2-(5-methoxy-5-oxo-2-
penten-1-yl)-3-oxo-cyclopentaneacetic
acid methyl ester
FA 14:4;O3C14H20O5268.1311